Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Nausea × Tablets × Clear all

Phase

Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Neoplasm Metastasis 2 Vomiting 1 Urinary Bladder Neoplasms 1 TP53 Y220C Mutation 1 Solid Tumors 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Neuroblastoma 1 Nausea 1 Myofibroma 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Carcinoma 1 Advanced Solid Tumors 1 Adenocarcinoma of Lung 1

Interventions

casopitant 2 Cyclophosphamide 2 Tablets 1 Methadone 1 Injections, Intravenous 1 Granisetron 1 Dronabinol 1 Docetaxel 1 Cannabidiol 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02563951 2016-01-08

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers

Maxinase Life Sciences Ltd.

Phase 1 Completed

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡